title: Profiling Loss of Heterozygosity Patterns in a Cohort of Favorable Histology Nephroblastoma Egyptian Patients: What is Consistent With the Rest of the World.
abstract: According to the Fifth National Wilms Tumor Study (NWTS-5), tumor-specific loss of heterozygosity (LOH) for chromosomes 1p and 16q identifies a subset of patients with Wilms tumor (WT) who despite having favorable histology (FH) have a significantly increased risk of relapse and death. We aimed to find out 1p and 16q LOH frequencies in patients with FH-WT as well as its correlation to survival outcome and epidemiologic and clinical characteristics. Data of patients with FH-WT presenting to the National Cancer Institute, Egypt, were retrospectively analyzed. Paraffin blocks were tested for 1p and 16q LOH using polymorphic loci that span the minimal regions of LOH at this area. The study included 100 patients with a median age of 5 years. Thirty-nine patients (39%) showed LOH at 1p (n = 14), 16q (n = 13), or both (n = 12). LOH was most frequently encountered in patients above 10 years (5/5), advanced stages disease (80% of stage V and 50% of stages IV and III each). The 3-year overall survival (OS) and event-free survival (EFS) were significantly lower in patients with double LOH (75% and 50%, respectively), followed by 16q (92% and 54%), in comparison with 1p (93% each) and negative LOH (97% and 100%) cases, respectively (p = 0.001). Combined LOH (1p+16q), followed by 16q LOH alone, was predictive of poorer outcome and was associated with lower OS and EFS in patients with FH-WT. Our results showed a higher-risk disease that would suggest the need for an intensified upfront therapy in this group of patients.
authors.affiliation: a Department of Pediatric Oncology , National Cancer Institute , Cairo , Egypt.
authors.forename: Mohamed
authors.initials: M
authors.lastname: Fawzy
authors.affiliation: b Department of Pathology , National Cancer Institute , Cairo , Egypt.
authors.forename: Abeer
authors.initials: A
authors.lastname: Bahanassy
authors.affiliation: c Department of Pediatrics , Armed Forces Hospitals , Egypt.
authors.forename: Amr
authors.initials: A
authors.lastname: Samir
authors.affiliation: a Department of Pediatric Oncology , National Cancer Institute , Cairo , Egypt.
authors.forename: Hanafy
authors.initials: H
authors.lastname: Hafez
mesh_terms: D002648:Child; D002675:Child, Preschool; D002878:Chromosomes, Human, Pair 1 / Q000235:genetics*; D018572:Disease-Free Survival; D004534:Egypt; D005260:Female; D056426:Genetic Loci; D006801:Humans; D007223:Infant; D007680:Kidney Neoplasms / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D019656:Loss of Heterozygosity; D008297:Male; D012189:Retrospective Studies; D015996:Survival Rate; D009396:Wilms Tumor / Q000235:genetics* / Q000401:mortality / Q000473:pathology
keywords: 16q; 1p; LOH; Wilms tumor; outcome